# A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers

> **NCT05007275** · PHASE1 · UNKNOWN · sponsor: **Imperial College London** · enrollment: 28 (actual)

## Conditions studied

- Covid19
- SARS-CoV-2 Infection

## Interventions

- **BIOLOGICAL:** 1x10^9 vp AZD1222
- **BIOLOGICAL:** 5x10^9 vp AZD1222
- **BIOLOGICAL:** 1x10^10 vp AZD1222

## Key facts

- **NCT ID:** NCT05007275
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-10
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-09-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05007275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05007275, "A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05007275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*